Bioactive medical technology for non-invasive wound healing and physiological stabilization in animals.

Title: Smart Healing Patch - Bioactive Multifunctional Wound Dressing with Integrated Thermoregulation and Real-Time Monitoring for Veterinary and Wildlife Applications 1. Technical Field The present invention relates generally to the field of bioactive medical technologies, specifically to a novel class of smart, biodegradable wound dressings designed for non-invasive wound healing, infection control, pain management, and physiological stabilization in animals. More particularly, the invention provides an integrated, multi-layer patch system incorporating antimicrobial nanoparticles, natural analgesic compounds, phase-change materials for thermoregulation, and embedded sensor technology for real-time monitoring of the wound healing process across diverse animal species. 2. Background of the Invention Wound management in veterinary medicine and wildlife rehabilitation presents unique challenges that conventional dressings fail to address adequately. Traditional bandages and gauze-based dressings provide passive protection but do not actively contribute to the healing process. They require frequent changes, cause pain and stress during removal, and offer no insight into the wound's internal healing progress. Furthermore, animals present diverse anatomical structures including fur, feathers, scales, and skin types with varying biochemical compositions, making a universal solution difficult. Wildlife rehabilitation scenarios often involve limited access to the animal after release, necessitating a "fit-and-forget" solution that continues working autonomously. Additionally, the growing global concern over antimicrobial resistance demands alternatives to conventional antibiotic treatments. There exists a need for an intelligent wound dressing system that can autonomously manage infection, alleviate pain, maintain optimal healing conditions, and provide remote monitoring capabilities while being completely biodegradable and species-adaptive. 3. Summary of the Invention The Smart Healing Patch is a revolutionary biodegradable, multi-layered adhesive patch system that autonomously promotes wound healing in animals through integrated bioactive mechanisms. The patch actively cleans infections, reduces pain locally, regulates wound temperature, and monitors healing progress without requiring external interventions or removal procedures. Key innovations of the invention include: · Autonomous infection control through synergistic action of antimicrobial nanoparticles and proteolytic enzymes embedded in a hydrogel matrix · Localized, on-demand pain management using natural analgesic compounds with pH/temperature-triggered release mechanisms · Dynamic thermoregulation via phase-change materials that maintain optimal wound temperature (approximately 37°C) regardless of environmental conditions · Real-time healing monitoring through flexible embedded sensors tracking temperature, pH, moisture, and infection biomarkers with wireless data transmission capabilities · Species-adaptive design with customizable adhesive interfaces and bioactive agent concentrations for diverse animal anatomies including mammals, birds, reptiles, and aquatic species · Complete biodegradability eliminating the need for painful dressing removal and reducing medical waste 4. Detailed Description of the Invention 4.1 Overall Structure and Layer Configuration The Smart Healing Patch comprises five functionally distinct yet integrated layers, arranged from the wound contact surface outward: 1. Bioactive Hydrogel Layer (wound-contacting) 2. Pain Relief Matrix Layer 3. Thermoregulatory Core Layer 4. Smart Monitoring Chip Layer (flexible electronic interface) 5. Protective Outer Membrane (environmental barrier) Each layer is engineered with specific material compositions and functionalities while maintaining overall flexibility, breathability, and biodegradability. 4.2 Layer 1: Bioactive Hydrogel Layer Composition and Materials: · Base Matrix: Cross-linked hydrogel comprising sodium alginate (derived from brown algae) and chitosan (derived from crustacean shells) in optimized ratios (60:40 to 80:20) to create a hydrophilic, moisture-retaining environment with inherent biocompatibility and mild antimicrobial properties · Antimicrobial Nanoparticles: Silver nanoparticles (AgNPs) with controlled size distribution (5-50 nm) at concentrations of 10-100 ppm, synthesized via green chemistry methods using plant extracts to ensure environmental safety · Enzymatic Components: · Lysozyme (0.1-1.0% w/v): Disrupts bacterial cell walls, particularly effective against Gram-positive bacteria · Bromelain or Papain (0.5-2.0% w/v): Proteolytic enzymes that perform enzymatic debridement of necrotic tissue and disrupt bacterial biofilms · Lactoferrin (optional): Iron-chelating protein with additional antimicrobial and anti-inflammatory properties · Growth Factors (optional): Epidermal Growth Factor (EGF) or Fibroblast Growth Factor (FGF) at nanogram concentrations to stimulate tissue regeneration in chronic or severe wounds Functional Mechanism: The hydrogel layer maintains a moist wound environment essential for optimal cell migration and proliferation. Upon contact with wound exudate, the gel absorbs excess fluid while releasing antimicrobial agents. Silver nanoparticles generate reactive oxygen species (ROS) that damage bacterial membranes and DNA, while enzymes degrade biofilm extracellular polymeric substances and remove devitalized tissue. The combination provides broad-spectrum antimicrobial activity against bacteria, fungi, and certain viruses while promoting granulation tissue formation. Biodegradation Profile: This layer undergoes gradual hydrolysis and enzymatic degradation over 7-21 days depending on wound conditions, with degradation products being naturally occurring sugars and amino acids that are safely metabolized or excreted. 4.3 Layer 2: Pain Relief Matrix Layer Composition and Materials: · Carrier Matrix: Biodegradable polymer film (polycaprolactone or poly(lactic-co-glycolic acid) - PLGA) electrospun into nanofibrous mesh providing high surface area for drug loading · Analgesic Agents: · Primary agent: Capsaicin-β-cyclodextrin inclusion complex (0.01-0.1% w/w equivalent capsaicin) - cyclodextrin encapsulation enables controlled release and reduces initial irritation · Secondary agent: Lidocaine base (1-5% w/w) or natural alternatives like menthol or camphor for immediate mild analgesia · Optional: Endogenous analgesic peptides (enkephalin analogs) incorporated for species-specific optimization · Release Control Mechanism: pH-responsive polymer coating (Eudragit or chitosan derivatives) that dissolves faster in acidic inflammatory environments (pH 5.5-6.5) compared to normal tissue pH (7.4) Functional Mechanism: The pain relief layer operates through a dual-mechanism approach. Capsaicin activates TRPV1 receptors on sensory neurons, causing initial depolarization followed by prolonged desensitization and reduced pain signal transmission. The pH-responsive coating ensures higher release rates in inflamed, acidic wound beds while minimizing release in healthy tissue. Lidocaine provides rapid-onset sodium channel blockade for immediate comfort. The nanofibrous structure enables sustained release over 3-7 days. 4.4 Layer 3: Thermoregulatory Core Layer Composition and Materials: · Phase-Change Material (PCM) Microcapsules: · Core material: Biocompatible paraffin waxes (e.g., n-eicosane, n-docosane) or fatty acid esters (methyl palmitate, methyl stearate) with melting points engineered to 32-37°C · Shell material: Polymerized melamine-formaldehyde or polyurea (food-grade, biocompatible) or biodegradable alternatives like poly(lactic acid) shells · Microcapsule size: 1-20 μm diameter to allow incorporation into flexible matrices · Support Matrix: Flexible silicone gel or polyurethane matrix (20-40% w/w PCM loading) providing mechanical integrity while allowing heat transfer Functional Mechanism: Phase-change materials absorb or release large amounts of latent heat during phase transition while maintaining constant temperature. When wound temperature exceeds the PCM melting point (e.g., due to inflammation or environmental heat), the PCM absorbs excess thermal energy, cooling the wound. Conversely, if environmental temperature drops below the PCM solidification point, the material releases stored heat, warming the wound. This passive, energy-free mechanism maintains wound temperature within the optimal 35-38°C range critical for enzymatic activity, immune cell function, and tissue regeneration. Thermal Regulation Capacity: With 30% PCM loading, a 10 cm² patch can absorb approximately 15-20 Joules of thermal energy per degree of temperature excursion, providing effective buffering for 2-4 hours of extreme temperature exposure before reaching equilibrium. 4.5 Layer 4: Smart Monitoring Chip Layer Hardware Components: · Flexible Substrate: Polyimide or PET film (25-100 μm thickness) with biocompatible encapsulation · Sensor Array: · Temperature sensor: Resistive or thermocouple-type with ±0.1°C accuracy · pH sensor: Iridium oxide or polyaniline-based potentiometric sensor · Moisture/humidity sensor: Capacitive or resistive interdigitated electrodes · Infection biomarker sensor (optional): Electrochemical immunosensor for C-reactive protein or procalcitonin · Microcontroller: Ultra-low-power ARM Cortex-M0 or similar with integrated analog-to-digital converter · Wireless Communication: NFC (Near-Field Communication) chip for passive power and data transfer, or Bluetooth Low Energy (BLE) module for continuous monitoring with coin cell battery · Antenna: Printed flexible copper or silver ink antenna optimized for 13.56 MHz (NFC) or 2.4 GHz (BLE) Data Processing and Transmissi